MARKET NEWS

New Research Sheds Light on Multi-Organ Adverse Events From Immunotherapy
Liminal BioSciences Announces Resubmission of Biologics License Application
Cymerus MSCs Demonstrate Efficacy in Preclinical Lung Disease Study
Spero Therapeutics Announces Positive Topline Results From its Phase 3 ADAPT-PO Clinical Trial
Vaxart’s Oral COVID-19 Vaccine Candidate Induces Potent Systemic & Mucosal Immune Responses 
Catalent Invests $130 Million to Add Additional Manufacturing Capacity at its Gene Therapy Campus

  FEATURED EDITORIAL

  COMPANY PROFILE

Lyophilization Technology, Inc. (LTI) is a Contract Development & Manufacturing Organization (CDMO) focused on all aspects of lyophilization for preparation of health care products. Clients leverage on our abilities for bringing new products to the clinic and implementing improvements for current products. Capitalize on over 25 years of excellence and our unparalleled capabilities in product development, process engineering, clinical manufacturing, and technical support. Click here for more.

  EXCLUSIVE ONLINE CONTENT

PhoreMost & XtalPi Sign AI-Based Collaboration Agreement

PhoreMost & XtalPi Sign AI-Based Collaboration Agreement

PhoreMost Limited and XtalPi Inc. recently announced they have entered into a drug discovery collaboration agreement…..

Exelixis & Catalent Enter Collaboration, License & Exclusive Option Agreement 

Exelixis & Catalent Enter Collaboration, License & Exclusive Option Agreement 

Exelixis, Inc. and Catalent recently announced a partnership under which Catalent’s Redwood Bioscience subsidiary will develop multiple antibody-drug conjugates (ADCs) for….

AnGes & Brickell Biotech Announce Collaboration Agreement for the Development of a Novel DNA Vaccine Candidate for COVID-19

AnGes & Brickell Biotech Announce Collaboration Agreement for the Development of a Novel DNA Vaccine Candidate for COVID-19

AnGes, Inc. recently announced a collaboration agreement with Brickell Biotech, Inc. through which Brickell has the right to develop AnGes’ proprietary….

Evonik Qualifies Advanced Aseptic Filling Line for Complex Parenteral Drug Products

Evonik Qualifies Advanced Aseptic Filling Line for Complex Parenteral Drug Products

Evonik recently announced the qualification of an advanced aseptic filling line for complex parenteral drug products at its FDA-inspected Birmingham….

  DRUG DEVELOPMENT DIRECT RESOURCES

Upcoming eNewsletter Features:

September 23 – Excipients
September 30 – Gene Therapy